Category: News

November 23, 2020

The U.S. Food and Drug Administration (FDA) has a busy end of November planned, with numerous PDUFA dates to address. Here’s a look at the upcoming week. Blueprint Medicines’ Pralsetinib for Non-Small Cell Lung Cancer Blueprint Medicines had a target […]

November 19, 2020

Catalent has appointed Behzad Mahdavi, Ph.D., MBA, as Vice President of Open Innovation, Biologics, Cell and Gene Therapy. In this new role, Dr. Mahdavi will join a team of experts in Catalent’s Science and Technology Group that works with customers […]

November 18, 2020

A vaccine created to prevent the recurrence of the deadly skin cancer melanoma is about twice as effective when patients also receive two components that boost the number and effectiveness of immune system dendritic cells (DCs), according to the results […]

November 3, 2020

FDA officials are pushing back against an executive order that will make it easier for President Donald Trump to fire federal employees, according to a report in Politico. Patrizia Cavazzoni, the acting head of the FDA’s drug center, is reportedly […]

November 2, 2020

Samsung Biologics (207940.KS) has entered into a strategic partnership with GeneQuantum Healthcare, a China biotech company, to jointly develop an antibody drug conjugate (ADC) for the treatment of non-small-cell lung carcinoma (NSCLC), triple-negative breast cancer (TNBC), and other solid tumors. […]

October 14, 2020

Staphylococcus aureus bacteria can be either a harmless resident of human skin, with one in four people harboring Staphylococcus aureus bacteria on their skin and mucous membranes of the upper respiratory tract, or a major pathogen wreaking havoc on our […]

October 1, 2020

The FDA has expanded its investigation into AstraZeneca’s COVID-19 vaccine to include data from clinical trials of prophylactics based on the same viral vector platform, Reuters reports. AstraZeneca quickly gained regulatory clearance to resume dosing in the U.K. part of […]

September 30, 2020

With tens of millions of Americans tuned in to Tuesday’s presidential debate, the race for a COVID-19 vaccine took center stage in a big way. President Donald Trump said we’re “weeks away” from a working shot, while Democratic nominee Joe […]

September 30, 2020

Scientists in the U.K. report that a new precision drug that stops cancer from repairing its DNA has shown promise in an early-stage clinical trial, highlighting the potential of a new class of drugs known as ATR inhibitors. The drug […]

September 17, 2020

Cancer treatments can be unsuccessful due to malignant cells surviving radiation, chemotherapy, or by evading apoptosis. Now researchers from the University of Tsukuba in Japan, demonstrate how the protein Livin—an apoptosis inhibitor—allows some lymphomas to resist therapy, and how targeting […]

September 16, 2020

The U.S. government plans to transport a coronavirus vaccine to distribution sites across the U.S. within 24 hours after the Food and Drug Administration grants an emergency authorization or approval, senior administration officials said Wednesday. The government will use medical […]

September 15, 2020

Timber Pharmaceuticals, Inc. (“Timber” or the “Company”) (NYSE American: TMBR), a biopharmaceutical company focused on the development and commercialization of treatments for orphan dermatologic diseases, today announced that it has received a formal notice of allowance from the U.S. Patent […]